MARC Record from marc_columbia

LEADER: 03180cam a22007698i 4500
001 11397215
005 20160123212235.0
008 140411t20152015mdua b 001 0 eng
010 $a 2014014551
016 7 $a101630296$2DNLM
019 $a894540030$a902012323$a905543397
020 $a9781421415932$q(hardcover : alk. paper)
020 $a1421415933$q(hardcover : alk. paper)
020 $z9781421415949$q(electronic)
020 $z1421415941$q(electronic)
029 1 $aNLM$b101630296
029 1 $aAU@$b000052776655
029 1 $aNLGGC$b391798308
029 1 $aCHVBK$b333798929
029 1 $aCHBIS$b010399321
035 $a(OCoLC)ocn877024247
035 $a(OCoLC)877024247$z(OCoLC)894540030$z(OCoLC)902012323$z(OCoLC)905543397
035 $a(NNC)11397215
040 $aDNLM/DLC$beng$erda$cDLC$dNLM$dBTCTA$dOCLCQ$dYDXCP$dIUL$dBDX$dOBE$dVET$dNLGGC$dKSU$dOCLCF$dSHH$dCHVBK
042 $apcc
043 $an-us---
050 4 $aRM267$b.P63 2015
060 00 $a2015 C-687
060 10 $aQV 11 AA1
060 4 $aQV 11 AA1$bP742a 2015
082 00 $a615.7/922$223
084 $a44.42$2bcl
100 1 $aPodolsky, Scott H.,$eauthor.
245 14 $aThe antibiotic era :$breform, resistance, and the pursuit of a rational therapeutics /$cScott H. Podolsky.
246 30 $aReform, resistance, and the pursuit of a rational therapeutics
264 1 $aBaltimore :$bJohns Hopkins University Press,$c[2015]
264 4 $c©2015
300 $axii, 309 pages :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references (pages 193-298) and index.
505 0 $aIntroduction -- The origins of antibiotic reform -- Antibiotics and the invocation of the controlled clinical trial -- From sigmamycin to panalba : antibiotics and the FDA -- "Rational" therapeutics and the limits to delimitation -- Responding to antibiotic resistance -- Conclusion.
650 0 $aAntibiotics$xHistory.
650 0 $aDrug resistance in microorganisms.
650 0 $aAntibacterial agents$xHistory.
650 0 $aPharmaceutical industry$zUnited States$xHistory.
650 0 $aDrug resistance.
650 12 $aAnti-Bacterial Agents$xhistory.
651 2 $aUnited States.
650 22 $aDrug Industry$xhistory.
650 22 $aDrug Resistance.
650 22 $aHistory, 20th Century.
650 22 $aLegislation, Drug$xhistory.
650 17 $aAntibiotica.$2gtt$0(NL-LeOCL)078433568
650 7 $aAntibacterial agents.$2fast$0(OCoLC)fst00810407
650 7 $aAntibiotics.$2fast$0(OCoLC)fst00810420
650 7 $aDrug resistance.$2fast$0(OCoLC)fst00898701
650 7 $aDrug resistance in microorganisms.$2fast$0(OCoLC)fst00898704
650 7 $aPharmaceutical industry.$2fast$0(OCoLC)fst01060129
651 7 $aUnited States.$2fast$0(OCoLC)fst01204155
650 7 $aAntibiotikum.$0(DE-588)4002257-2$2gnd
650 7 $aTherapie.$0(DE-588)4059798-2$2gnd
650 7 $aResistenz.$0(DE-588)4136408-9$2gnd
651 7 $aUSA.$0(DE-588)4078704-7$2gnd
655 7 $aHistory.$2fast$0(OCoLC)fst01411628
852 00 $boff,hsl$hRM267$i.P63 2015